Bayer Intellectual Property Gmbh

Bayer Schering Pharma Ag

Bayer Healthcare Aktiengesellschaft

Timo Flessner

Joachim Luithle

Christina Erb

Christoph Methfessel

Marja Van Kampen

Katrin Schnizler

Frank-Thorsten Hafner

Frank-Gerhard Böss

Franz-Josef Van Der Staay

Frank-Gerhard Boess

Frank-Gerhard Böβ

Leila Telan

Marja V Kampen

Frank-Gerhard Bob

Hilmar Bischoff

Dieter Lang

Peter Kolkhof

Nils Griebenow

Martin Hendrix

Anja Buchmüller

Michael Härter

Peter Ellinghaus

Frank-Gerhard Böb

Katrin Schnitzler

Martin Raabe

Frank-Gerhard BÖβ

Welf Burkhard Wiese

Frank-Gerhard Boss

The invention relates to novel amides of acetic and propionic acids, methods for production and use thereof for the production of medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning ability and memory.

Amides of acetic and propionic acids

The invention relates to novel 2-heteroaryl carboxamides and to the use thereof for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory.

2-heteroaryl carboxamides

The invention relates to N-biarylamides useful for the prophylaxis and/or treatment of impairments of perception, concentration, learning and/or memory, and to processes for preparing them, and pharmaceutical compositions containing them.

N-biarylamides

The invention relates to novel benzothiophene-, benzofuran-, and indole ureas and to the use thereof for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning, and/or memory.

Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists

The present application relates to novel tetrahydrobenzo[d]azepin-2-one derivatives, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for producing medicaments for the treatment and/or prophylaxis of diseases, preferably for the treatment and/or prevention of cardiovascular disorders, especially of dyslipidaemias, arteriosclerosis, restenosis and ischaemias.

Tetrahydrobenzo[d]azepin-2-one derivatives and the use thereof for treating cardiovascular diseases

This application relates to bicyclic N-aryl amides of the formula Ris a-aza-bicyclo[]octyl group, a-aza-bicyclo[]oct--yl; Ris an optionally sustituted- to- membered heteroaryl, naphthyl, or azulenyl group; and Ris H or (CC)alkyl; or a salt, solvate, or solvate of a salt of these compounds. A process for preparing these compounds, medicaments containing them, and methods for using them in treatment are also disclosed and claimed.

Bicyclic N-arylamides

The invention relates to novel 1-aza-bicyclic N-biarylamides, methods for production and use thereof for the production of medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning ability and memory.

Aza-bicyclic N-biarylamides with affinity for the &#x3b1;7 nicotinic acetylcholine receptor

Growing community of inventors

Wuppertal, Germany

Timo Flessner